|

Nivolumab [Opdivo] Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Vinblastine, brentuximab vedodin

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • University Hospital Tuebingen1
  • New York Medical College1

Indications

  • Cancer2
  • Leptomeningeal Disease1
  • Anaplastic Large Cell Lymphoma, ALK-Positive1

Other1 trial

Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
Phase 1

Valhalla, New York1 trial

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

New York Medical College

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.